High Prices For Orphan Drugs Strain Families And Insurers
Three decades ago, Congress set up a system to encourage drug companies to develop treatments for rare diseases. The law has worked, but at a high cost.
Pharmaceuticals
A Raise Can Wreak Havoc With Your Health Insurance Subsidy
Health insurance subsidies are pegged to personal income estimates. But if those are too low, a person may have to repay the government later on.
Morning Sickness Pill Gets Second Look From Persistent Researchers
The American Congress of Obstetricians and Gynecologists says pregnant women with morning sickness shouldn't reach hastily for the pill bottle. Controversy over one medicine called Diclegis continues.
Where Does Alzheimer's Treatment Go From Here?
The failure of an experimental drug that targets clumps of protein inside the brains of Alzheimer's patients called into question one of the leading theories about the cause of the dementia.
Looking For Bargains, Many Americans Buy Medicines Abroad
Eight percent of respondents in a recent national poll said they or someone in their household had imported a prescription drug to the U.S. at some point. Are the deals as good as they seem?
Mylan To Sell Generic EpiPen At Half The Price Of Original
Drugmaker Mylan is launching a generic version of its own EpiPen. The lower price could quiet criticism about the high cost of the brand-name anti-allergy drug. There's also a business twist.
States Accuse Generic Drugmakers Of Price Fixing
Six drug companies are being sued for working together to manipulate prices on their generic versions of two widely used medicines.
A Growing Group Of Doctors Are Big-Money Prescribers In Medicare
In 2011, just 41 health care providers prescribed more than $5 million each in medicines under Medicare Part D. In 2015, that number was 514. The rise of expensive hepatitis C drugs is a factor.
Biomedical Researchers Ponder Future After Trump Election
The federal government spends more than $30 billion a year to fund the National Institutes of Health. How will a new administration affect academic research? What about pharmaceutical research?
Safety Of Painkiller Celebrex Affirmed In New Study
A large study alleviates concerns that Celebrex boosts the risk for heart attacks and strokes as much as Vioxx. But the findings raise some concerns about prescription doses of ibuprofen and naproxen.